152226
AEC Substrate Buffer
This AEC Substrate Buffer is validated for use in Immunoblotting and Immunohistochemistry.
別名:
AEC Substrate
製品名
AEC Substrate Buffer, This AEC Substrate Buffer is validated for use in Immunoblotting and Immunohistochemistry.
form
liquid
does not contain
preservative
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
shipped in
ambient
storage temp.
2-8°C
Quality Level
Application
AEC Substrate Buffer has been used in memory B cells enzyme-linked immune absorbent spot (ELISpot) assay.
Disclaimer
Toxicity: Standard Handling (A)
General description
AEC Substrate Buffer is a peroxidase substrate buffer supplied as a 10X concentrate (pH 5.0 when diluted). It is used as a diluent for 3-Amino-9-ethylcarbazole (AEC), a widely used chromogen for immunohistochemical staining.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1
保管分類
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Substances Subject to be Notified Names
ishl_notified
152226-ML: + 152226-50ML:
jan
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Nadine G Rouphael et al.
NPJ vaccines, 6(1), 89-89 (2021-07-16)
In a phase 1 randomized, single-center clinical trial, inactivated influenza virus vaccine delivered through dissolvable microneedle patches (MNPs) was found to be safe and immunogenic. Here, we compare the humoral and cellular immunologic responses in a subset of participants receiving
Evan J Anderson et al.
Vaccines, 8(1) (2020-02-12)
Background: Vaccinia is known to induce antibody and cellular responses. Plasmablast, circulating follicular helper T (cTFH) cells, cytokine-expressing CD4 T cells, and memory B cells were compared between subcutaneous (SC) and needle-free jet injection (JI) recipients of non-replicating modified vaccinia
Hermann O Mayr et al.
Archives of orthopaedic and trauma surgery, 139(3), 383-391 (2019-01-19)
Arthrofibrosis (AF) is the result of increased cell proliferation and synthesis of matrix proteins (collagen I, III, and VI). Especially after invasive knee surgery, e.g., ligament reconstruction or knee replacement, abnormal fibroblast proliferation with pathological periarticular fibrosis can be observed
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）